GSK Investigational Site

Camberwell, Victoria 3124

1 studies enrolling now · 6 studies all time

What they study most

COVID-19, Osteoarthritis, Knee, Pain, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Infections+Metapneumovirus, SARS-CoV-2

Studies at this site

• A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults — Recruiting now
• A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years — Completed
• An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study — Running, not enrolling
• A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain — Stopped early
• A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults — Completed
• Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above — Completed